Structure (Lidocaine Hydrochoride Injection Preserved 1)
Lidocaine Injection, Solution
Product Images NDC 0143-9577
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 0143-9577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2% 2 mL Vial X 25 February 2015 (Lidocaine Hydrochoride Injection Preserved 10)
This is a description of a medication named Lidocaine HCI Injection, USP, which comes with the National Drug Code 0143-9575-01. The medication is not to be used for epidural or caudal purposes. The text also mentions Welhyaraben 3 Presratie ey and provides a code for the medication, i.e., PP 000y 525. However, the text is incomplete and hard to understand due to errors.*
2% 50 mL February 2015 (Lidocaine Hydrochoride Injection Preserved 11)
This is a description of a sterile and non-pyrogenic injection containing Lidocaine HCI, Lidocaine sodium chloride, and methylparaben. The solution should not be used if it appears discolored or contains a precipitate. The package insert should be consulted for the usual dosage. The injection is available in 10 x 50 mL multiple dose vials and must be stored between 20°C to 25°C. The text also mentions the use of sodium hydroxide and/or hydrochloric acid to adjust the pH level.*
2% 50 mL X 10 February 2015 (Lidocaine Hydrochoride Injection Preserved 12)
This text contains product information including the GTIN, SN or serial number, and expiration date, as well as a lot number.*
West-ward Logo (Lidocaine Hydrochoride Injection Preserved 2)
This is a product label for Lidocaine HCI Injection, USP, with a concentration of 1% and 20mg/2mL (10mg/mL). The product is intended for "mfiraton and Terve bioek." The label includes a warning that it is "Not For Eoidurator." There are also several unclear words and lines of text, including "Yeitar o," "St opebissvil," and "S e v Tl oo Pl." The label also includes a Lot and Exp number.*
1% 2 mL Vial February 2015 (Lidocaine Hydrochoride Injection Preserved 3)
This is a description of a medication called "Lidocaine HCI Injection, USP" which is intended for infiltration and nerve block use only. It is not meant to be used for epidural or caudal purposes. The medication is provided in a 252 ml multiple-dose vial, with each mL containing lidocaine HCI 10 mg, sodium chloride 7 mg, and methylparaben 1 mg. The dosage should be determined by the package insert and the medication should not be used if it appears discolored or contains a precipitate. It should be stored at temperatures between 20°C and 25°C.*
1% 2 mL Vial X 25 February 2015 (Lidocaine Hydrochoride Injection Preserved 4)
Description: Lidocaine HCI Injection is a medication used for formation and nerve block purposes. It comes in multiple dose vials and each ml contains 10mg of lidocaine HCI. This medication is not recommended for epidural or caudal use. The usual dosage varies according to the package insert. The medication must be stored between 20° C to 25°C (68° to 77°F), and it should be kept at a controlled room temperature. It is produced by S Y Westward.*
1% 30 mL February 2015 (Lidocaine Hydrochoride Injection Preserved 5)
This is a description of Lidocaine HCI Injection, USP, which is a local anesthetic medication used for infiltration and nerve block. The solution is available in 300 mg/30 mL (10 mg/mL) concentration in a 1030 mL multiple dose vial that is sterile and nonpyrogenic. It contains lidocaine HCI, sodium chloride, methylparaben, and sodium hydroxide or hydrochloric acid to adjust the pH level. The usual dosage instructions can be found on the package insert. The solution must not be used if it is discolored or contains any precipitate. The solution should be stored at 20° to 25°C (66° to 77°F). It is manufactured by Acmeca, Portugal, and distributed by Westward.*
1% 30 mL X 10 February 2015 (Lidocaine Hydrochoride Injection Preserved 6)
NDC 0143-9577-01 is a 10 mg Lidocaine HCI Injection, USP used for infiltration and nerve block. It comes in a 500mg/10mL vial with sodium chloride. It is recommended to store it between 20-25°C (68-77°F) and should be used for Epidural or Causal use under controlled room temperature. The medicine contains Methylparaben as a preservative.*
1% 50 mL February 2015 (Lidocaine Hydrochoride Injection Preserved 7)
This is a description of a medication that is contained in a vial with instructions to cut the seal in order to open it. The medication is sterile, non-pyrogenic, and contains lidocaine HCI, lidocaine sodium chloride, methylparaben, sodium hydroxide, and/or hydrochloric HCI Injection. It is usually used for infiltration and nerve block and should not be used for epidural or caudal use. Dosage instructions can be found in the package insert. The manufacturer is Hikma Farmageutica in Portugal, and the medication is distributed by Hina in the USA in 10x50 mL multiple dose vials.*
1% 50 mL X 10 February 2015 (Lidocaine Hydrochoride Injection Preserved 8)
The text is a combination of scrambled and misspelled words and does not provide a useful description. It appears to be a label of a medication containing Lidocaine HCI Injection with dosage and instructions for use.*
2% 2 mL Vial February 2015 (Lidocaine Hydrochoride Injection Preserved 9)
This is a description of the Lidocaine HCI Injection, USP, which is meant for infiltration and nerve block. It should not be used for epidural or caudal use. It is contained in 25x2 mL multiple dose vials with methyiparaben as a preservative. The solution also contains lidocaine HCI 20 mg, sodium chloride, melhyparaben, sodium hydroxide, and/or hydrochiricacd to adjust the pH. Its usual dosage is available in the package insert. It must not be used if the solution is discolored or contains a precipitate. It should be stored at 20° to 25°C (68° to 77°F).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
